These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 16974069)

  • 1. Identification of amino acid residues important for sarpogrelate binding to the human 5-hydroxytryptamine2A serotonin receptor.
    Muntasir HA; Rashid M; Komiyama T; Kawakami J; Nagatomo T
    J Pharmacol Sci; 2006 Sep; 102(1):55-63. PubMed ID: 16974069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Site-directed mutagenesis of the serotonin 5-Hydroxytryptamine2c receptor: identification of amino acids responsible for sarpogrelate binding.
    Muntasir HA; Takahashi J; Rashid M; Ahmed M; Komiyama T; Hossain M; Kawakami J; Nashimoto M; Nagatomo T
    Biol Pharm Bull; 2006 Aug; 29(8):1645-50. PubMed ID: 16880620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a key amino acid of the human 5-HT(2B) serotonin receptor important for sarpogrelate binding.
    Muntasir HA; Hossain M; Bhuiyan MA; Komiyama T; Nakamura T; Ozaki M; Nagatomo T
    J Pharmacol Sci; 2007 Jul; 104(3):274-7. PubMed ID: 17609583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inverse agonist activity of sarpogrelate, a selective 5-HT2A-receptor antagonist, at the constitutively active human 5-HT2A receptor.
    Muntasir HA; Bhuiyan MA; Ishiguro M; Ozaki M; Nagatomo T
    J Pharmacol Sci; 2006 Oct; 102(2):189-95. PubMed ID: 17031071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of the binding sites and selectivity of sarpogrelate, a novel 5-HT2 antagonist, to human 5-HT2A, 5-HT2B and 5-HT2C receptor subtypes by molecular modeling.
    Rashid M; Manivet P; Nishio H; Pratuangdejkul J; Rajab M; Ishiguro M; Launay JM; Nagatomo T
    Life Sci; 2003 May; 73(2):193-207. PubMed ID: 12738034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding and functional affinity of sarpogrelate, its metabolite m-1 and ketanserin for human recombinant alpha-1-adrenoceptor subtypes.
    Israilova M; Suzuki F; Tanaka T; Nagatomo T; Taniguchi T; Muramatsu I
    Pharmacology; 2002 May; 65(2):69-73. PubMed ID: 11937776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of binding affinity to 5-hydroxytryptamine 2A (5-HT2A) receptor and inverse agonist activity of naftidrofuryl: comparison with those of sarpogrelate.
    Aly SA; Hossain M; Bhuiyan MA; Nakamura T; Nagatomo T
    J Pharmacol Sci; 2009 Aug; 110(4):445-50. PubMed ID: 19672037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Site-directed mutagenesis of the serotonin 5-hydroxytrypamine2 receptor: identification of amino acids necessary for ligand binding and receptor activation.
    Wang CD; Gallaher TK; Shih JC
    Mol Pharmacol; 1993 Jun; 43(6):931-40. PubMed ID: 8316224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contribution of a helix 5 locus to selectivity of hallucinogenic and nonhallucinogenic ligands for the human 5-hydroxytryptamine2A and 5-hydroxytryptamine2C receptors: direct and indirect effects on ligand affinity mediated by the same locus.
    Almaula N; Ebersole BJ; Ballesteros JA; Weinstein H; Sealfon SC
    Mol Pharmacol; 1996 Jul; 50(1):34-42. PubMed ID: 8700116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential modes of agonist binding to 5-hydroxytryptamine(2A) serotonin receptors revealed by mutation and molecular modeling of conserved residues in transmembrane region 5.
    Shapiro DA; Kristiansen K; Kroeze WK; Roth BL
    Mol Pharmacol; 2000 Nov; 58(5):877-86. PubMed ID: 11040033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Binding affinity of sarpogrelate, a new antiplatelet agent, and its metabolite for serotonin receptor subtypes.
    Nishio H; Inoue A; Nakata Y
    Arch Int Pharmacodyn Ther; 1996; 331(2):189-202. PubMed ID: 8937629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism of inverse agonist action of sarpogrelate at the constitutively active mutant of human 5-HT2A receptor revealed by molecular modeling.
    Hossain M; Muntasir HA; Ishiguro M; Bhuiyan MA; Rashid M; Sugihara T; Nagatomo T
    Biol Pharm Bull; 2012; 35(9):1553-9. PubMed ID: 22975508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple conformations of native and recombinant human 5-hydroxytryptamine(2a) receptors are labeled by agonists and discriminated by antagonists.
    López-Giménez JF; Villazón M; Brea J; Loza MI; Palacios JM; Mengod G; Vilaró MT
    Mol Pharmacol; 2001 Oct; 60(4):690-9. PubMed ID: 11562430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dysregulated 5-HT(2A) receptor binding in postmortem frontal cortex of schizophrenic subjects.
    Muguruza C; Moreno JL; Umali A; Callado LF; Meana JJ; González-Maeso J
    Eur Neuropsychopharmacol; 2013 Aug; 23(8):852-64. PubMed ID: 23176747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contribution of the peripheral 5-HT 2A receptor to mechanical hyperalgesia in a rat model of neuropathic pain.
    Nitanda A; Yasunami N; Tokumo K; Fujii H; Hirai T; Nishio H
    Neurochem Int; 2005 Nov; 47(6):394-400. PubMed ID: 16051396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of ligand-induced desensitization of the 5-hydroxytryptamine(2A) receptor.
    Hanley NR; Hensler JG
    J Pharmacol Exp Ther; 2002 Feb; 300(2):468-77. PubMed ID: 11805206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of homogeneous high-affinity agonist binding assays for 5-HT2 receptor subtypes.
    Song J; Hanniford D; Doucette C; Graham E; Poole MF; Ting A; Sherf B; Harrington J; Brunden K; Stricker-Krongrad A
    Assay Drug Dev Technol; 2005 Dec; 3(6):649-59. PubMed ID: 16438660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of a high-affinity ketanserin binding site at the 5-Hydroxytryptamine(1B) receptor by modification of its carboxy-terminal intracellular portion.
    Wurch T; Palmier C; Pauwels PJ
    Biochem Pharmacol; 2000 May; 59(9):1117-21. PubMed ID: 10704941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Binding affinity of sarpogrelate to 5-HT(2A) receptor ligand recognition sites in rat renal cortical and mesangial cells in culture.
    Nishio H; Yoshikawa S; Morimoto Y; Chen Z; Nakata Y
    Gen Pharmacol; 1999 Jul; 33(1):51-7. PubMed ID: 10428016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutations of transmembrane IV and V serines indicate that all tryptamines do not bind to the rat 5-HT2A receptor in the same manner.
    Johnson MP; Wainscott DB; Lucaites VL; Baez M; Nelson DL
    Brain Res Mol Brain Res; 1997 Oct; 49(1-2):1-6. PubMed ID: 9387857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.